![](/img/cover-not-exists.png)
Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment
Józefa Węsierska-Gądek, Andreea Borza, Eva Walzi, Vladimir Krystof, Margarita Maurer, Oxana Komina, Stefanie WandlVolume:
106
Year:
2009
Language:
english
Pages:
19
DOI:
10.1002/jcb.22074
File:
PDF, 908 KB
english, 2009